Broadcasting
Compare Stocks
2 / 10Stock Comparison
CURI vs FUBO
Revenue, margins, valuation, and 5-year total return — side by side.
Broadcasting
CURI vs FUBO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Broadcasting | Broadcasting |
| Market Cap | $179M | $364M |
| Revenue (TTM) | $72M | $2.72B |
| Net Income (TTM) | $-6M | $156M |
| Gross Margin | 56.6% | 11.1% |
| Operating Margin | -10.2% | -2.6% |
| Forward P/E | 86.9x | — |
| Total Debt | $12M | $670M |
| Cash & Equiv. | $18M | $452M |
CURI vs FUBO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| CuriosityStream Inc. (CURI) | 100 | 31.1 | -68.9% |
| fuboTV Inc. (FUBO) | 100 | 8.9 | -91.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CURI vs FUBO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CURI carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 1.44, yield 12.6%
- -64.3% 10Y total return vs FUBO's -88.9%
- Lower volatility, beta 1.44, Low D/E 30.0%, current ratio 1.23x
FUBO is the clearest fit if your priority is growth exposure.
- Rev growth 67.7%, EPS growth 96.3%, 3Y rev CAGR 39.2%
- 67.7% revenue growth vs CURI's 40.1%
- 5.7% margin vs CURI's -9.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 67.7% revenue growth vs CURI's 40.1% | |
| Quality / Margins | 5.7% margin vs CURI's -9.0% | |
| Stability / Safety | Beta 1.44 vs FUBO's 1.77 | |
| Dividends | 12.6% yield; 2-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +5.2% vs FUBO's -59.0% | |
| Efficiency (ROA) | 8.1% ROA vs CURI's -8.2%, ROIC -3.3% vs -12.2% |
CURI vs FUBO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CURI vs FUBO — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
FUBO leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
FUBO is the larger business by revenue, generating $2.7B annually — 38.0x CURI's $72M. FUBO is the more profitable business, keeping 5.7% of every revenue dollar as net income compared to CURI's -9.0%. On growth, FUBO holds the edge at +2.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $72M | $2.7B |
| EBITDAEarnings before interest/tax | $14M | -$14M |
| Net IncomeAfter-tax profit | -$6M | $156M |
| Free Cash FlowCash after capex | $13M | -$81M |
| Gross MarginGross profit ÷ Revenue | +56.6% | +11.1% |
| Operating MarginEBIT ÷ Revenue | -10.2% | -2.6% |
| Net MarginNet income ÷ Revenue | -9.0% | +5.7% |
| FCF MarginFCF ÷ Revenue | +18.1% | -3.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +35.8% | +2.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -31.2% | +81.8% |
Valuation Metrics
FUBO leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $179M | $364M |
| Enterprise ValueMkt cap + debt − cash | $173M | $582M |
| Trailing P/EPrice ÷ TTM EPS | -27.64x | -51.67x |
| Forward P/EPrice ÷ next-FY EPS est. | 86.86x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 23.42x | — |
| Price / SalesMarket cap ÷ Revenue | 2.49x | 0.13x |
| Price / BookPrice ÷ Book value/share | 4.23x | 0.14x |
| Price / FCFMarket cap ÷ FCF | 13.78x | — |
Profitability & Efficiency
FUBO leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
FUBO delivers a 16.2% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-13 for CURI. FUBO carries lower financial leverage with a 0.25x debt-to-equity ratio, signaling a more conservative balance sheet compared to CURI's 0.30x. On the Piotroski fundamental quality scale (0–9), CURI scores 5/9 vs FUBO's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -13.1% | +16.2% |
| ROA (TTM)Return on assets | -8.2% | +8.1% |
| ROICReturn on invested capital | -12.2% | -3.3% |
| ROCEReturn on capital employed | -13.6% | -4.1% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 |
| Debt / EquityFinancial leverage | 0.30x | 0.25x |
| Net DebtTotal debt minus cash | -$6M | $218M |
| Cash & Equiv.Liquid assets | $18M | $452M |
| Total DebtShort + long-term debt | $12M | $670M |
| Interest CoverageEBIT ÷ Interest expense | — | 10.35x |
Total Returns (Dividends Reinvested)
CURI leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CURI five years ago would be worth $2,572 today (with dividends reinvested), compared to $574 for FUBO. Over the past 12 months, CURI leads with a +5.2% total return vs FUBO's -59.0%. The 3-year compound annual growth rate (CAGR) favors CURI at 54.2% vs FUBO's -11.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -17.0% | -60.1% |
| 1-Year ReturnPast 12 months | +5.2% | -59.0% |
| 3-Year ReturnCumulative with dividends | +266.3% | -29.7% |
| 5-Year ReturnCumulative with dividends | -74.3% | -94.3% |
| 10-Year ReturnCumulative with dividends | -64.3% | -88.9% |
| CAGR (3Y)Annualised 3-year return | +54.2% | -11.1% |
Risk & Volatility
CURI leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CURI is the less volatile stock with a 1.44 beta — it tends to amplify market swings less than FUBO's 1.77 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CURI currently trades 42.5% from its 52-week high vs FUBO's 21.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.44x | 1.77x |
| 52-Week HighHighest price in past year | $7.15 | $56.64 |
| 52-Week LowLowest price in past year | $2.81 | $2.48 |
| % of 52W HighCurrent price vs 52-week peak | +42.5% | +21.9% |
| RSI (14)Momentum oscillator 0–100 | 45.6 | 51.9 |
| Avg Volume (50D)Average daily shares traded | 343K | 1.8M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates CURI as "Buy" and FUBO as "Hold". Consensus price targets imply 246.8% upside for FUBO (target: $43) vs 20.7% for CURI (target: $4). CURI is the only dividend payer here at 12.56% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $3.67 | $43.00 |
| # AnalystsCovering analysts | 9 | 14 |
| Dividend YieldAnnual dividend ÷ price | +12.6% | — |
| Dividend StreakConsecutive years of raises | 2 | — |
| Dividend / ShareAnnual DPS | $0.38 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
FUBO leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). CURI leads in 2 (Total Returns, Risk & Volatility).
CURI vs FUBO: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is CURI or FUBO a better buy right now?
For growth investors, fuboTV Inc.
(FUBO) is the stronger pick with 67. 7% revenue growth year-over-year, versus 40. 1% for CuriosityStream Inc. (CURI). Analysts rate CuriosityStream Inc. (CURI) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — CURI or FUBO?
Over the past 5 years, CuriosityStream Inc.
(CURI) delivered a total return of -74. 3%, compared to -94. 3% for fuboTV Inc. (FUBO). Over 10 years, the gap is even starker: CURI returned -64. 3% versus FUBO's -88. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — CURI or FUBO?
By beta (market sensitivity over 5 years), CuriosityStream Inc.
(CURI) is the lower-risk stock at 1. 44β versus fuboTV Inc. 's 1. 77β — meaning FUBO is approximately 23% more volatile than CURI relative to the S&P 500. On balance sheet safety, fuboTV Inc. (FUBO) carries a lower debt/equity ratio of 25% versus 30% for CuriosityStream Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — CURI or FUBO?
By revenue growth (latest reported year), fuboTV Inc.
(FUBO) is pulling ahead at 67. 7% versus 40. 1% for CuriosityStream Inc. (CURI). On earnings-per-share growth, the picture is similar: fuboTV Inc. grew EPS 96. 3% year-over-year, compared to 54. 2% for CuriosityStream Inc.. Over a 3-year CAGR, FUBO leads at 39. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — CURI or FUBO?
fuboTV Inc.
(FUBO) is the more profitable company, earning 5. 7% net margin versus -9. 0% for CuriosityStream Inc. — meaning it keeps 5. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FUBO leads at -2. 6% versus -10. 2% for CURI. At the gross margin level — before operating expenses — CURI leads at 56. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is CURI or FUBO more undervalued right now?
Analyst consensus price targets imply the most upside for FUBO: 246.
8% to $43. 00.
07Which pays a better dividend — CURI or FUBO?
In this comparison, CURI (12.
6% yield) pays a dividend. FUBO does not pay a meaningful dividend and should not be held primarily for income.
08Is CURI or FUBO better for a retirement portfolio?
For long-horizon retirement investors, CuriosityStream Inc.
(CURI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (12. 6% yield). fuboTV Inc. (FUBO) carries a higher beta of 1. 77 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CURI: -64. 3%, FUBO: -88. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between CURI and FUBO?
Both stocks operate in the Communication Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
CURI pays a dividend while FUBO does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 17%
- Gross Margin > 33%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.